The depletion of donor macrophages reduces ischaemia-reperfusion injury after mouse lung transplantation

European Journal of Cardio-thoracic Surgery

Volumn 45, Issue 4, 2014, Pages 703-709

  Tsushima, Yukio ^a,b   Jang, Jae Hwi ^a   Yamada, Yoshito ^a,c   Schwendener, Reto ^d   Suzuki, Kenji ^b   Weder, Walter ^a   Jungraithmayr, Wolfgang ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c CHIBA UNIVERSITY   (Japan)

^d Institute of Molecular Cancer Research   (Switzerland)

Author keywords

Ischaemia reperfusion injury; Lung; Macrophage depletion; Mouse; Transplantation

Indexed keywords

CLODRONIC ACID; HIGH MOBILITY GROUP B1 PROTEIN; LACTATE DEHYDROGENASE; LIPOSOME; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL COUNT; CELL DAMAGE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEPLETION; DONOR; ENZYME LINKED IMMUNOSORBENT ASSAY; HOMEOSTASIS; IMMUNOHISTOCHEMISTRY; LACTATE DEHYDROGENASE BLOOD LEVEL; LUNG ALVEOLUS MACROPHAGE; LUNG INJURY; LUNG TRANSPLANTATION; MALE; MOUSE; NONHUMAN; OXYGENATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REPERFUSION INJURY; ANIMAL; BAGG ALBINO MOUSE; BLOOD; CYTOLOGY; LUNG; METABOLISM; TRANSPLANTATION;

ANIMALS; CLODRONIC ACID; CYTOKINES; LIPOSOMES; LUNG; LUNG TRANSPLANTATION; MACROPHAGES, ALVEOLAR; MALE; MICE; MICE, INBRED BALB C; REPERFUSION INJURY; TRANSPLANTS;

EID: 84896447529     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1093/ejcts/ezt489     Document Type: Article

References (23)

1. Fiser S M, Tribble C G, Long S M, Kaza A K, Cope J T, Laubach V E et al. Lung transplant reperfusion injury involves pulmonary macrophages and circulating leukocytes in a biphasic response. J Thorac Cardiovasc Surg 2001;121:1069-75.
2. Madjdpour C, Jewell U R, Kneller S, Ziegler U, Schwendener R, Booy C et al. Decreased alveolar oxygen induces lung inflammation. Am J Physiol Lung Cell Mol Physiol 2003;284:L360-367.
3. Sharma A K, Linden J, Kron I L, Laubach V E. Protection from pulmonary ischemia-reperfusion injury by adenosine A2A receptor activation. Respir Res 2009;10:58.
4. Sekine Y, Bowen L K, Heidler K M, Van Rooijen N, Brown J W, Cummings OWet al. Role of passenger leukocytes in allograft rejection: effect of depletion of donor alveolar macrophages on the local production of TNF-alpha, T helper 1/T helper 2 cytokines, IgG subclasses, and pathology in a rat model of lung transplantation. J Immunol 1997;159:4084-93.
5. De Perrot M, Sekine Y, Fischer S, Waddell T K, McRae K, Liu M et al. Interleukin-8 release during early reperfusion predicts graft function in human lung transplantation. Am J Respir Crit Care Med 2002;165:211-5.
6. Maxey T S, Enelow R I, Gaston B, Kron I L, Laubach V E, Doctor A. Tumor necrosis factor-alpha from resident lung cells is a key initiating factor in pulmonary ischemia-reperfusion injury. J Thorac Cardiovasc Surg 2004;127:541-7.
7. Naidu B V, Krishnadasan B, Farivar A S, Woolley S M, Thomas R, Van Rooijen N et al. Early activation of the alveolar macrophage is critical to the development of lung ischemia-reperfusion injury. J Thorac Cardiovasc Surg 2003;126:200-7.
8. Zhao M, Fernandez L G, Doctor A, Sharma A K, Zarbock A, Tribble C G et al. Alveolar macrophage activation is a key initiation signal for acute lung ischemia-reperfusion injury. Am J Physiol Lung Cell Mol Physiol 2006;291:L1018-1026.
9. Jungraithmayr W M, Korom S, Hillinger S, Weder W. A mouse model of orthotopic, single-lung transplantation. J Thorac Cardiovasc Surg 2009;137:486-91.
10. van Rooijen N, Hendrikx E. Liposomes for specific depletion of macrophages from organs and tissues. Methods Mol Biol 2010;605:189-203.
11. Beck-Schimmer B, Schwendener R, Pasch T, Reyes L, Booy C, Schimmer R C. Alveolar macrophages regulate neutrophil recruitment in endotoxininduced lung injury. Respir Res 2005;6:61.
12. Nakamura T, Abu-Dahab R, Menger M D, Schafer U, Vollmar B, Wada H et al. Depletion of alveolar macrophages by clodronate-liposomes aggravates ischemia-reperfusion injury of the lung. J Heart Lung Transplant 2005;24:38-45.
13. de Perrot M, Liu M, Waddell T K, Keshavjee S. Ischemia-reperfusioninduced lung injury. Am J Respir Crit Care Med 2003;167:490-511.
14. Eppinger M J, Deeb G M, Bolling S F, Ward P A. Mediators of ischemia-reperfusion injury of rat lung. Am J Pathol 1997;150:1773-84.
15. Ross S D, Tribble C G, Gaughen J R Jr, Shockey K S, Parrino P E, Kron I L. Reduced neutrophil infiltration protects against lung reperfusion injury after transplantation. Ann Thorac Surg 1999;67:1428-33. discussion 1434.
16. Khimenko P L, Bagby G J, Fuseler J, Taylor A E. Tumor necrosis factor-alpha in ischemia and reperfusion injury in rat lungs. J Appl Physiol 1998;85:2005-11.
17. Krishnadasan B, Naidu B V, Byrne K, Fraga C, Verrier E D, Mulligan M S. The role of proinflammatory cytokines in lung ischemia-reperfusion injury. J Thorac Cardiovasc Surg 2003;125:261-72.
18. Fischer S, Cassivi S D, Xavier A M, Cardella J A, Cutz E, Edwards V et al. Cell death in human lung transplantation: apoptosis induction in human lungs during ischemia and after transplantation. Ann Surg 2000;231:424-31.
19. Fischer S, Maclean A A, Liu M, Cardella J A, Slutsky A S, Suga M et al. Dynamic changes in apoptotic and necrotic cell death correlate with severity of ischemia-reperfusion injury in lung transplantation. Am J Respir Crit Care Med 2000;162:1932-9.
20. Andrassy M, Volz H C, Igwe J C, Funke B, Eichberger S N, Kaya Z et al. High-mobility group box-1 in ischemia-reperfusion injury of the heart. Circulation 2008;117:3216-26.
21. Ng C S, Wan S, Yim A P. Pulmonary ischaemia-reperfusion injury: role of apoptosis. Eur Respir J 2005;25:356-63.
22. Pittet J F, Griffiths M J, Geiser T, Kaminski N, Dalton S L, Huang X et al. TGF-beta is a critical mediator of acute lung injury. J Clin Invest 2001;107:1537-44.
23. Fiser S M, Tribble C G, Long S M, Kaza A K, Kern J A, Kron I L. Pulmonary macrophages are involved in reperfusion injury after lung transplantation. Ann Thorac Surg 2001;71:1134-8. discussion 1138-1139.